Your browser is no longer supported. Please, upgrade your browser.
Settings
ARLZ Aralez Pharmaceuticals Inc. daily Stock Chart
ARLZ [NASD]
Aralez Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own2.80% Shs Outstand353.57M Perf Week-83.19%
Market Cap17.54M Forward P/E- EPS next Y-0.56 Insider Trans-2.03% Shs Float60.76M Perf Month-80.60%
Income-117.50M PEG- EPS next Q-0.32 Inst Own17.00% Short Float4.89% Perf Quarter-89.53%
Sales118.10M P/S0.15 EPS this Y-5.30% Inst Trans-1.00% Short Ratio1.38 Perf Half Y-97.07%
Book/sh-0.10 P/B- EPS next Y33.30% ROA-24.80% Target Price3.00 Perf Year-95.36%
Cash/sh0.12 P/C0.40 EPS next 5Y30.00% ROE-329.10% 52W Range0.04 - 2.98 Perf YTD-96.51%
Dividend- P/FCF- EPS past 5Y-15.90% ROI-31.10% 52W High-98.34% Beta-
Dividend %- Quick Ratio0.80 Sales past 5Y81.70% Gross Margin81.10% 52W Low14.02% ATR0.06
Employees105 Current Ratio0.80 Sales Q/Q46.50% Oper. Margin-76.20% RSI (14)26.01 Volatility41.66% 23.49%
OptionableYes Debt/Eq- EPS Q/Q29.60% Profit Margin-99.50% Rel Volume2.87 Prev Close0.06
ShortableYes LT Debt/Eq- EarningsAug 15 Payout- Avg Volume2.16M Price0.05
Recom2.00 SMA20-81.64% SMA50-84.85% SMA200-95.79% Volume6,197,357 Change-21.27%
Feb-05-18Initiated H.C. Wainwright Buy $6
Aug-10-17Reiterated Chardan Capital Markets Buy $5.50 → $4
Mar-15-17Reiterated Chardan Capital Markets Buy $10 → $5.50
Mar-16-16Reiterated Chardan Capital Markets Buy $15.50 → $10
Aug-10-18 01:16PM  [$$] Drug Company Aralez Files for Bankruptcy, Plans to Sell Most Assets The Wall Street Journal -83.14%
06:00AM  Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets PR Newswire
Jun-29-18 06:10PM  Aralez Enters Into Amendment To Second Amended And Restated Facility Agreement PR Newswire
06:10PM  Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders PR Newswire
07:10AM  Anthera Pharma and Three Additional Stocks Under Scanner in the Biotech Space ACCESSWIRE
Jun-01-18 01:22PM  Interested In Aralez Pharmaceuticals Inc (TSE:ARZ)? Heres How It Performed Recently Simply Wall St. -5.68%
May-23-18 07:00AM  Free Daily Technical Summary Reports on Amicus Therapeutics and Three Other Biotech Stocks ACCESSWIRE +6.50%
May-15-18 05:26PM  Is There An Opportunity With Aralez Pharmaceuticals Incs (TSE:ARZ) 39% Undervaluation? Simply Wall St. -7.07%
May-09-18 11:56AM  Edited Transcript of ARLZ earnings conference call or presentation 8-May-18 12:00pm GMT Thomson Reuters StreetEvents -17.75%
08:20AM  Todays Research Reports on Stocks to Watch: Amedica Corporation and Aralez Pharmaceuticals ACCESSWIRE
07:48AM  Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway Benzinga
May-08-18 07:26AM  Aralez Pharmaceuticals: 1Q Earnings Snapshot Associated Press -67.34%
06:57AM  Aralez Announces First Quarter 2018 Financial Results PR Newswire
06:55AM  Aralez Announces New Strategic Direction PR Newswire
Apr-27-18 07:00AM  Aralez To Announce First Quarter 2018 Results On May 8, 2018 PR Newswire +5.26%
Apr-01-18 11:21PM  Edited Transcript of ARLZ earnings conference call or presentation 13-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Mar-27-18 01:00PM  Will Aralez Pharmaceuticals Incs (TSE:ARZ) Earnings Grow In The Next Couple Of Years? Simply Wall St. -6.62%
Mar-26-18 04:05PM  Eyenovia Appoints Three Industry Veterans to Board of Directors GlobeNewswire
Mar-19-18 10:00AM  ARLZ: Aralez Set for Strong Revenue Growth in 2018 Zacks Small Cap Research
Mar-13-18 07:00AM  Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results PR Newswire -13.86%
07:00AM  Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results CNW Group
06:30AM  Aralez Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 08:00AM  Select Sands Appoints Mr. Daniel Gillett and Mr. Steven Goldman to the Board of Directors GlobeNewswire
07:00AM  Aralez To Announce Fourth Quarter And Full-Year 2017 Results On March 13, 2018 PR Newswire
07:00AM  Aralez To Announce Fourth Quarter And Full-Year 2017 Results On March 13, 2018 CNW Group
Feb-22-18 08:11AM  How Financially Strong Is Aralez Pharmaceuticals Inc (TSE:ARZ)? Simply Wall St.
Feb-13-18 12:37PM  Why Aralez Pharmaceuticals Inc (TSE:ARZ) Could Be A Buy Simply Wall St.
Jan-30-18 07:00AM  Aralez to Present at the 2018 BIO CEO and Investor Conference PR Newswire
07:00AM  Aralez to Present at the 2018 BIO CEO and Investor Conference CNW Group
Jan-16-18 10:01AM  Is Aralez Pharmaceuticals Inc (TSE:ARZ) On The Right Side Of Disruption? Simply Wall St. -5.06%
Dec-28-17 11:35AM  Does Aralez Pharmaceuticals Incs (TSE:ARZ) CEO Salary Compared Well With Others? Simply Wall St.
Dec-20-17 03:13PM  Who Are The Major Shareholders In Aralez Pharmaceuticals Inc (TSE:ARZ)? Simply Wall St.
Dec-01-17 11:24AM  Where Aralez Pharmaceuticals Inc (TSX:ARZ) Stands In Terms Of Earnings Growth Against Its Industry Simply Wall St.
08:13AM  Aralez Pharmaceuticals, Inc. :ARLZ-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 Capital Cube
Nov-30-17 05:00PM  Aralez Announces Departure of Chief Financial Officer PR Newswire +5.59%
05:00PM  Aralez Announces Departure of Chief Financial Officer CNW Group
Nov-16-17 04:13PM  Are Aralez Pharmaceuticals Incs (TSX:ARZ) Interest Costs Too High? Simply Wall St. +6.45%
Nov-13-17 06:00PM  ARLZ: Increasing Revenue Projections for 2018 Zacks Small Cap Research
Nov-10-17 08:10AM  Todays Research Reports on Stocks to Watch: Aralez Pharmaceuticals and Sage Therapeutics ACCESSWIRE -10.99%
Nov-09-17 02:12PM  Edited Transcript of ARLZ earnings conference call or presentation 9-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
07:32AM  Aralez Pharmaceuticals reports 3Q loss Associated Press
07:00AM  Aralez Announces Third Quarter 2017 Financial Results And Achieves Profitability on an Adjusted EBITDA Basis for the First Time in the Third Quarter CNW Group
Nov-02-17 01:08PM  Estimating The Intrinsic Value Of Aralez Pharmaceuticals Inc (TSX:ARZ) Simply Wall St. +33.79%
Oct-25-17 07:00AM  Aralez To Report Third Quarter 2017 Financial Results On November 9, 2017 CNW Group
Oct-04-17 02:30PM  Edited Transcript of ARLZ earnings conference call or presentation 9-Aug-17 1:00pm GMT Thomson Reuters StreetEvents +8.30%
Sep-05-17 07:55PM  ETFs with exposure to Aralez Pharmaceuticals, Inc. : September 5, 2017 Capital Cube
Aug-25-17 12:02PM  Aralez Pharmaceuticals, Inc. :ARLZ-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-10-17 03:00PM  ARLZ: Looking to Capitalize on Successful Launch of Zontivity® Zacks Small Cap Research -12.50%
Aug-09-17 07:00AM  Aralez Reports Second Quarter 2017 Financial Results PR Newswire
07:00AM  Aralez Reports Second Quarter 2017 Financial Results CNW Group
Jul-24-17 07:00AM  Aralez To Report Second Quarter 2017 Financial Results On August 9, 2017 PR Newswire
Jul-10-17 04:00PM  ARLZ: Promising Early Data Following Launch of Zontivity®; VIMOVO® Patents Upheld Zacks Small Cap Research
Jun-29-17 08:15AM  Corporate News Blog - Aralez Announced District Court Decision to Uphold VIMOVO Patents Accesswire
Jun-27-17 07:00AM  Aralez Announces District Court Decision to Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents PR Newswire
07:00AM  Aralez Announces District Court Decision to Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents CNW Group
Jun-07-17 06:30AM  Aralez Announces National U.S. Commercial Launch Of Zontivity PR Newswire -7.03%
06:30AM  Aralez Announces National U.S. Commercial Launch Of Zontivity CNW Group
06:00AM  Aralez Announces Board Member Resignation CNW Group
May-23-17 07:00AM  Aralez to present at the Jefferies Healthcare Conference PR Newswire
May-18-17 09:15AM  Edited Transcript of ARLZ earnings conference call or presentation 9-May-17 1:00pm GMT Thomson Reuters StreetEvents +8.84%
May-15-17 01:00PM  ARLZ: Zontivity to be Officially Launched in June 2017 Zacks Small Cap Research
May-12-17 10:50AM  Aralez Pharmaceuticals, Inc. :ARLZ-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
09:26AM  Edited Transcript of ARLZ earnings conference call or presentation 9-May-17 1:00pm GMT Thomson Reuters StreetEvents
08:00AM  Today's Research Reports on Stocks to Watch: DryShips and Aralez Pharmaceuticals Accesswire
May-09-17 08:51AM  Aralez Pharmaceuticals reports 1Q loss Associated Press +6.61%
08:30AM  Investor Network: Aralez Pharmaceuticals Inc. to Host Earnings Call Accesswire
07:00AM  Aralez Reports First Quarter 2017 Financial Results PR Newswire
07:00AM  Aralez Reports First Quarter 2017 Financial Results CNW Group
May-03-17 05:20PM  Aralez Announces Voting Results From 2017 Annual And Special Meeting Of Shareholders CNW Group -7.84%
Apr-25-17 07:00AM  Aralez To Report First Quarter 2017 Financial Results On May 9, 2017 PR Newswire
07:00AM  Aralez To Report First Quarter 2017 Financial Results On May 9, 2017 CNW Group
Apr-06-17 07:30AM  Today's Research Reports on Stocks to Watch: Aralez Pharmaceuticals and Innocoll Holdings Accesswire -11.86%
Apr-05-17 06:30AM  Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program PR Newswire -16.51%
Mar-30-17 09:54AM  Biotech Premarket Movers: Halozyme, Omeros, Aralez
Mar-23-17 04:55PM  ARALEZ PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Mar-22-17 08:36AM  Aralez Pharmaceuticals, Inc. :ARLZ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017 Capital Cube
Mar-21-17 09:57AM  Aralez Pharmaceuticals, Inc. :ARLZ-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017 Capital Cube
Mar-20-17 04:23PM  Jazz Pharma Isn't Dozing; Stock Breaks Out On Sleep Apnea Trial
06:30AM  Aralez CEO Purchases 500,000 Shares Of Company Common Stock On Open Market PR Newswire
06:30AM  Aralez CEO Purchases 500,000 Shares Of Company Common Stock On Open Market CNW Group
Mar-16-17 01:04PM  ARALEZ PHARMACEUTICALS INC. Financials -7.17%
01:00PM  ARLZ: 2016 Financial Results and Guidance for 2017 Zacks Small Cap Research
Mar-13-17 03:47PM  Why Aralez Pharmaceuticals Inc. Got Slaughtered Today Motley Fool -30.31%
09:00AM  Aralez Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today
07:42AM  Aralez Pharmaceuticals reports 4Q loss Associated Press
07:07AM  Q4 2016 Aralez Pharmaceuticals Inc Earnings Release - Before Market Open
06:54AM  ARALEZ PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu
06:30AM  Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results PR Newswire
06:30AM  Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results CNW Group
Mar-02-17 06:03AM  ARALEZ PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Feb-27-17 06:30AM  Aralez To Announce Fourth Quarter And Full-Year 2016 Results On March 13, 2017 PR Newswire
Feb-16-17 02:00PM  Aralez to Present at the RBC Capital Markets Global Healthcare Conference PR Newswire
Feb-13-17 10:00AM  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
06:30AM  Aralez To Ring Closing Bell At Nasdaq On February 14, 2017 PR Newswire
Jan-27-17 04:22PM  ARALEZ PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
09:46AM  Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen
Jan-25-17 03:00PM  ARLZ: Aralez Attains Formulary Status for YOSPRALA from Express Scripts and CVS Caremark
Jan-13-17 04:22PM  ARALEZ PHARMACEUTICALS INC. Files SEC form 8-K/A, Financial Statements and Exhibits
Jan-11-17 06:00AM  Aralez Announces Issuance Of Additional U.S. Patent For Yosprala PR Newswire
Jan-09-17 06:15AM  Aralez Submits Marketing Authorization Application To The European Medicines Agency For PA10040 PR Newswire
Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in the United States and Canada. It engages in acquiring, developing, and commercializing products in the areas of cardiovascular, pain management, dermatological allergy, and other indications. It offers Zontivity for the reduction of thrombotic cardiovascular events in patients with heart attack or peripheral arterial disease; Toprol-XL, a cardioselective beta-blocker that is indicated for the treatment of hypertension; Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia and patients with primary hypercholesterolemia or mixed dyslipidemia; and Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial. The company also markets Cambia, a non-steroidal anti-inflammatory drug (NSAID) for the acute treatment of migraine attacks; Soriatane for the treatment of severe psoriasis and other disorders of keratinization; Proferrin, an iron supplement; Fiorinal and Fiorinal C for the relief of tension type headaches; and Bezalip SR, a pan-peroxisome proliferator-activated receptor activator to treat hyperlipidemia, as well as to increase insulin sensitivity and decrease blood glucose levels for the patients with metabolic syndrome. In addition, it provides out-licensed products, which include VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers; and Treximet, a migraine medicine. The company was incorporated in 2015 and is headquartered in Mississauga, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOVEN ANDREW IPresident & Chief Business OffJun 04Sale0.37156,57358,5901,183,419Jun 06 05:00 PM
KOVEN ANDREW IPresident & Chief Business OffMay 14Sale0.5213,9647,2611,339,992May 16 07:50 PM
Tursi James PatrickChief Medical OfficerMay 14Sale0.529,3484,882242,052May 16 07:49 PM
Trachtenberg EricGC, CCO & SecretaryMar 19Sale1.703,4715,901198,093Mar 21 05:16 PM
Glickman Mark AChief Commercial OfficerMar 19Sale1.705,7259,733250,188Mar 21 05:15 PM
KOVEN ANDREW IPresident & Chief Business OffMar 19Sale1.709,73916,5561,353,956Mar 21 05:16 PM
Tursi James PatrickChief Medical OfficerMar 19Sale1.705,95010,115251,400Mar 21 05:16 PM
Kirsch Arthur SDirectorDec 08Buy1.4750,00073,535271,609Dec 12 07:00 AM
Tursi James PatrickChief Medical OfficerOct 02Sale2.509,96024,918257,350Oct 04 08:32 PM